Taking people in ItalyNo phase
Testing blood samples for DNA repair gene changes in metastatic prostate cancer
Studies a new testing method using blood samples in adults with metastatic prostate cancer.
Key facts
- Who runs it
- European Institute of Oncology
- Where
- Milan, ItalySee the site
- Trial code
- Registry title
- Implementation of a New Algorithm for HRR Gene Mutation Testing in Patients With mPC Through Liquid Biopsy Integration
- Status
- Recruiting
- People taking part
- 125 people, planned
- Started
- 20 Dec 2024
- Expected to end
- 31 Dec 2030
- Type of study
- Observational
- Record updated
- 15 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for men with prostate cancer that has spread, whose tumour tissue is missing or not good enough for gene testing.
- Age
- 18 years or older
- Sex
- Men only
- Disease stage
- Metastatic prostate cancer (cancer that has spread)
- Biomarker or test result
- The trial tests for HRR gene changes. Tumour tissue must be unavailable or inadequate for molecular testing.
Main reasons for not taking part
- Cannot give written informed consent
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Patients with metastatic prostate cancer whose tumor tissue is unavailable or inadequate for molecular testing. • Written informed consent must be signed and dated by the patient and the investigator prior to inclusion
Who cannot take part
- Unable to provide written informed consent
Where in Italy
- European Institute of OncologyMilan, ItalyContact: elena Guerini Rocco, MDTaking people
About the trial
What the trial wants to find out
Implementation of a new algorithm for HRR gene mutation testing in patients with mPC through liquid biopsy integration
The group in the trial
- patient with metastatic prostate cancer (mPC)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Implementation of a New Algorithm for HRR Gene Mutation Testing in Patients With mPC
- Plain-language title
- Testing blood samples for DNA repair gene changes in metastatic prostate cancerGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 15 September 2026